Nine Bilkent University R&D Projects Awarded TÜSEB Funding

June 19, 2026 Written by ttoweb

The results of TÜSEB’s 2026 Group A and Group B R&D funding calls in the fields of health sciences and technologies have been announced. Nine projects from Bilkent University were awarded funding through the two programs, which support graduate students (Group A) and full-time academic researchers (Group B).

According to TÜSEB data, 454 projects under Group A and 182 projects under Group B were selected for funding in the 2026 calls. The funding rates were 35.83% and 22.30%, respectively. Bilkent University achieved an overall success rate of approximately 45% in these calls. We congratulate our researchers and wish them a productive and successful project period.

Group B Awarded Projects

• Onur Çizmecioğlu (MBG) – Investigation of Ferroptotic Vulnerability in Cystinosis Genotypes Specific to the Turkish Population through Functional and Multi-Omics Analyses

• Engin Durgun (UNAM) – Development of a Molecularly Imprinted Optical Sensor for Rapid Detection of Cervical Cancer Based on Extracellular Vesicles

• Özlem Aybüke Işık Bozbay (MBG) – Nerve–tumor crosstalk and novel combination therapy strategies in PIK3CA-H1047R mutant breast cancer

Group A Awarded Projects

• Bülend Ortaç (UNAM) – Use of an 808 nm-Excited UCNP-LOx-PO Ratiometric Nanosensor Platform for Rapid Lactate Detection (Collaborative Project)

• Aleyna Nur Akatay (MBG) – Combinatorial Targeting of PI3K and Sphingomyelin Metabolism in Castration-Resistant Prostate Cancer

• Muazzez Çelebi Çınar (MBG) – BrainPrism: A Web Application for Cell-Type-Specific Transcriptome Mapping from Bulk RNA-seq Data in Mouse Brain Tissue

• Nil Kılıç (UNAM) – Investigation of Non-Coding RNA-Mediated Immunomodulatory Effects of Lung Cancer Cell-Derived Exosomes on NK-92 Cell Functions

• Gizem Sunar Çetin (UNAM) – Investigating the Role of Triple-Negative Breast Cancer-Derived Extracellular Vesicles in Lung Pre-Metastatic Niche Dynamics

• Dilşad Taydaş Tolga (UNAM) – Development of Therapeutic Thermo-Responsive P(NIPAM-co-AAm)-Based Microneedles for Fever Treatment and Evaluation of Their Efficacy in an In Vivo Mouse Fever Model

Uncategorized
Similar posts
  • Academia and Industry Came Together for New Beginnings — The event “New Beginnings for Collaboration: Academia–Industry Dialogues II”, organized by Bilkent University Technology Transfer Office (Bilkent TTO), was held on June 16, 2026. The event brought together company representatives from various sectors and researchers from Bilkent University and Bilkent UNAM to strengthen university–industry collaboration, promote joint R&D and innovation projects, and establish new research [...]
  • “Navigating ERC Funding: Insights for Researchers” Event — The Bilkent University Technology Transfer Office (TTO) and the Middle East Technical University (METU) Project Development Office (PDO) successfully co-hosted “Navigating ERC Funding: Insights for Researchers” at the Bilkent UNAM Conference Hall on June 9, 2026. The European Research Council (ERC) stands as the premier tier of frontier research funding in Europe. To support our [...]
  • Bilkent Success in TÜBİTAK 2232-B Program: Two of Our Resea... — Bilkent University will host two researchers in 2025 as part of the TÜBİTAK 2232-B International Fellowship for Young Researchers Program. Dr. Enis Kaya from the Department of Mathematics has been awarded support for his project titled “The quadratic Chabauty method at primes of bad reduction & rational points on modular curves.” The project focuses on [...]
  • Bilkent Boosts Horizon Europe Proposal Capacity through IMS... — Bilkent University, through its Technology Transfer Office (TTO) and as an active member of the Information Multipliers System (IMS) Club, participated in a two-day “Proposal Writing in Horizon Europe” programme held under the “Technical Assistance for Türkiye in Horizon Europe Project”. The programme was opened by TUBITAK National Coordinator of Horizon Europe Programme Çağrı Yıldırım [...]
  • TÜBİTAK Hosts Horizon Europe MSCA Calls Conference Day in A... — TÜBİTAK organized a comprehensive event on 15 April 2026 at the Feza Gürsey Conference Room in Ankara, focusing on the Marie Skłodowska-Curie Actions (MSCA) under Horizon Europe. The event brought together researchers, institutional representatives, and experts to explore funding opportunities and proposal strategies within MSCA. The programme opened with remarks by TÜBİTAK President Prof. Dr. [...]

Archives